March 2014

Debate Continues on Initiating Therapy for High-Risk Smoldering Myeloma

March 26, 2014

Clinical Articles

In most malignancies, early detection and intervention are prerequisites for a possible cure. Consequently, why is the standard of care for myeloma a watch-and-wait approach, with no treatment until progression?

Minimal Residual Disease (MRD) Marches to Front Line of Myeloma Research

April 01, 2014

Clinical Articles

More than two dozen abstracts at the December 2013 meeting of the American Society of Hematology (ASH) focused on the detection, measurement, or monitoring of MRD in patients with multiple myeloma.

Trials Explore Treatments for Elderly Patients With CLL

April 04, 2014

Clinical Articles

Treatment of CLL is complicated by the fact that most patients are diagnosed at a later age, with a median age at diagnosis of 72 years. In the United States, 75% of patients with CLL are more than 65 years of age.